^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in dextrose 5% in sodium chloride 0.225%.

^e Tested in Ringer’s injection, lactated.

^f Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^g Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^h Test performed using the formulation WITH edetate disodium.

ⁱ Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^j Tested in sodium chloride 0.45%.

^k Tested as the premixed infusion solution.

^l Tested with epinephrine (PAR) 16 mcg/mL in dextrose 5%.

^m Tested with epinephrine (PAR) 32 mcg/mL in dextrose 5%.

ⁿ Tested with epinephrine (PAR) 64 mcg/mL in dextrose 5%.

^o Tested with heparin sodium (MEI) 2 units/mL in sodum chloride 0.9%.

^p Tested with heparin sodium (HOS) 2 units/mL premixed infusion solution in sodium chloride 0.9%.

^q Tested with heparin sodium (MEI) 100 units/mL in sodium chloride 0.45%.

^r Tested with heparin sodium (HOS) 100 units/mL premixed infusion solution in sodium chloride 0.45%.

^s Tested with milrinone lactate (HIK) 200 mcg/mL premixed infusion solution in dextrose 5%.

^t Tested with milrinone lactate (HIK) 200 mcg/mL in dextrose 5%.

^u Tested with milrinone lactate (HIK) 400 mcg/mL in dextrose 5%.

^v Tested with vasopressin (PAR) 0.2 unit/mL in dextrose 5%.

^w Tested with vasopressin (PAR) 1 unit/mL in dextrose 5%.

^x Run at 0.72 mL/hr.

^y Run at 0.36 mL/hr.

^z Salt not specified.

^aa Tested in dextrose 20% in sodium chloride 0.45%.

^bb Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.

^cc Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.